GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » Forward PE Ratio

Livzon Pharmaceutical Group (SZSE:000513) Forward PE Ratio : 0.00 (As of May. 21, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group Forward PE Ratio?

Livzon Pharmaceutical Group's Forward PE Ratio for today is 0.00.

Livzon Pharmaceutical Group's PE Ratio without NRI for today is 16.14.

Livzon Pharmaceutical Group's PE Ratio for today is 18.05.


Livzon Pharmaceutical Group Forward PE Ratio Historical Data

The historical data trend for Livzon Pharmaceutical Group's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Forward PE Ratio Chart

Livzon Pharmaceutical Group Annual Data
Trend
Forward PE Ratio

Livzon Pharmaceutical Group Quarterly Data
Forward PE Ratio

Competitive Comparison of Livzon Pharmaceutical Group's Forward PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Livzon Pharmaceutical Group's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Livzon Pharmaceutical Group's Forward PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Livzon Pharmaceutical Group's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Livzon Pharmaceutical Group's Forward PE Ratio falls into.



Livzon Pharmaceutical Group Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Livzon Pharmaceutical Group  (SZSE:000513) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Livzon Pharmaceutical Group Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Livzon Pharmaceutical Group (SZSE:000513) Business Description

Traded in Other Exchanges
Address
38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines